By analyzing data from TCGA-PAAD dataset, we found that TGFBR2 was high expressed in PC patients and the USP33 mRNA expression was positively correlated with TGFBR2 (Fig. 5A, B). This evidence concerns the gene TGFBR2 and pancreatic adenocarcinoma.